GAMES
10
MIN
9.6
PTS
3.7
REB
1.3
AST
0.1
FG%
57.1
Season averages
| Season | Phase | Team | GP | GS | MIN | PTS | REB | AST | 3PM | S+B | FG% | 3P% | FT% | PIR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABA League | ||||||||||||||
| 2024-25 | Regular season |  SPA | 10 | 0 | 9.6 | 3.7 | 1.3 | 0.1 | 0.1 | 0.7 | 57.1 | 50.0 | 66.7 | 3.2 |
| Basketball Champions League | ||||||||||||||
| 2021-22 | Regular season |  RYT | 2 | 0 | 3.5 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 25.0 | — | — | — |
| Lietuvos krepšinio lyga | ||||||||||||||
| 2021-22 | Regular season | RYT | 4 | 0 | 8.2 | 3.5 | 2.0 | 0.3 | 0.0 | 1.8 | 66.7 | — | 60.0 | 4.8 |
| ABA League | ||||||||||||||
| 2019-20 | Regular season |  FMP | 17 | 9 | 11.7 | 5.4 | 1.8 | 0.2 | 0.1 | 1.1 | 54.0 | 22.2 | 43.1 | 4.1 |
| Orlen Basket Liga | ||||||||||||||
| 2018-19 | Regular season | AKO | 26 | 18 | 21.1 | 13.0 | 5.8 | 0.7 | 0.2 | 1.5 | 56.2 | 19.0 | 55.9 | 14.2 |
| ABA League | ||||||||||||||
| 2016-17 | Regular season |  MEG | 17 | 0 | 14.3 | 6.9 | 2.3 | 1.1 | 0.5 | 1.0 | 53.8 | 56.3 | 65.7 | 5.5 |
| Basketball Champions League | ||||||||||||||
| 2016-17 | Regular season | MEG | 8 | 0 | 17.1 | 6.8 | 4.6 | 0.4 | 0.1 | 0.8 | 34.7 | 9.1 | 59.4 | — |
| ABA League | ||||||||||||||
| 2015-16 | Regular season |  CZV | 14 | 0 | 11.0 | 3.9 | 1.8 | 0.9 | 0.1 | 0.7 | 52.4 | 22.2 | 50.0 | 4.0 |
| EuroLeague | ||||||||||||||
| 2015-16 | Regular season | CZV | 11 | 3 | 5.7 | 0.7 | 1.1 | 0.5 | 0.0 | 0.3 | 20.0 | 0.0 | 33.3 | 0.0 |
| ABA League | ||||||||||||||
| 2014-15 | Regular season | CZV | 24 | 0 | 10.9 | 2.4 | 2.0 | 0.8 | 0.2 | 0.7 | 41.5 | 27.8 | 42.9 | 2.3 |
| EuroLeague | ||||||||||||||
| 2014-15 | Regular season | CZV | 17 | 4 | 8.9 | 1.6 | 1.4 | 0.7 | 0.2 | 0.2 | 35.7 | 33.3 | 37.5 | 0.1 |
| ABA League | ||||||||||||||
| 2014-15 | Playoffs | CZV | 6 | 0 | 10.7 | 1.3 | 1.2 | 1.0 | 0.0 | 0.2 | 30.8 | 0.0 | — | -0.3 |
| 2013-14 | Regular season | CZV | 13 | 0 | 7.8 | 2.2 | 1.2 | 0.4 | 0.3 | 0.5 | 47.4 | 44.4 | 50.0 | 1.4 |
| EuroLeague | ||||||||||||||
| 2013-14 | Regular season | CZV | 1 | 1 | 14.9 | 4.0 | 2.0 | 1.0 | 0.0 | 0.0 | 66.7 | 0.0 | — | 2.0 |
| EuroCup | ||||||||||||||
| 2013-14 | Playoffs | CZV | 7 | 1 | 7.1 | 1.4 | 1.4 | 0.1 | 0.0 | 0.4 | 37.5 | 0.0 | 100.0 | 1.7 |
Advanced — true shooting, usage, per-36 rates
| Season | Phase | GP | MIN | TS% | eFG% | USG% | TOV% | 3PAr | FTr | PTS/36 | REB/36 | AST/36 | S+B/36 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-25 ABA League | Regular season | 10 | 96 | 60.4 | 58.9 | 16.4 | 8.9 | 0.07 | 0.21 | 13.9 | 4.9 | 0.4 | 2.6 |
| 2021-22 Lietuvos krepšinio lyga | Regular season | 4 | 33 | 67.3 | 66.7 | 21.2 | 27.8 | 0.00 | 1.67 | 15.3 | 8.8 | 1.1 | 7.7 |
| 2019-20 ABA League | Regular season | 17 | 198 | 53.8 | 55.6 | 25.2 | 19.0 | 0.14 | 0.81 | 16.7 | 5.6 | 0.5 | 3.3 |
| 2018-19 Orlen Basket Liga | Regular season | 26 | 549 | 58.5 | 57.1 | 27.4 | 10.5 | 0.09 | 0.63 | 22.2 | 10.0 | 1.2 | 2.6 |
| 2016-17 ABA League | Regular season | 17 | 243 | 61.8 | 59.4 | 21.3 | 18.7 | 0.20 | 0.44 | 17.5 | 5.8 | 2.7 | 2.5 |
| 2016-17 Basketball Champions League | Regular season | 8 | 137 | 42.8 | 35.7 | 23.8 | 13.7 | 0.22 | 0.65 | 14.2 | 9.7 | 0.8 | 1.6 |
| 2015-16 ABA League | Regular season | 14 | 154 | 55.1 | 54.8 | 18.3 | 16.9 | 0.21 | 0.38 | 12.6 | 5.8 | 3.0 | 2.3 |
| 2015-16 EuroLeague | Regular season | 11 | 62 | 22.7 | 20.0 | 15.2 | 10.2 | 0.33 | 0.40 | 4.6 | 6.9 | 3.5 | 1.7 |
| 2014-15 ABA League | Regular season | 24 | 261 | 46.6 | 46.2 | 13.8 | 18.4 | 0.34 | 0.40 | 8.0 | 6.8 | 2.6 | 2.3 |
| 2014-15 EuroLeague | Regular season | 17 | 152 | 42.8 | 42.9 | 11.8 | 18.2 | 0.43 | 0.29 | 6.4 | 5.4 | 2.8 | 0.7 |
| 2014-15 ABA League | Playoffs | 6 | 64 | 30.8 | 30.8 | 10.1 | 0.0 | 0.38 | 0.00 | 4.5 | 3.9 | 3.4 | 0.6 |
| 2013-14 ABA League | Regular season | 13 | 101 | 57.6 | 57.9 | 13.6 | 10.7 | 0.47 | 0.74 | 10.3 | 5.7 | 1.8 | 2.5 |
| 2013-14 EuroCup | Playoffs | 7 | 50 | 51.2 | 37.5 | 12.4 | 23.5 | 0.25 | 0.50 | 7.2 | 7.2 | 0.7 | 2.2 |
Box-score approximations: usage without play-by-play, shooting from season totals. Rates are per 36 minutes.
Season
2024-252021-222019-202018-192016-172015-162014-152013-14
Recent form
PointsReboundsAssistsThreesPts+Reb+Ast
Next up · CLU 79.9% more points allowed to forwards than the league average (46 vs 25.57) · 1 games+79.9%
Points over 9.0 in 1/10
Last 15 games — 2019-20
| Date | Opp | Result | MIN | PTS | REB | AST | 3PM | PRA | +/- |
|---|---|---|---|---|---|---|---|---|---|
| 9 Mar | vs CZV | L 79-87 | 4 | 0 | 0 | 1 | 0 | 1 | -11 |
| 1 Feb | vs COL | L 100-105 | 14 | 5 | 1 | 0 | 0 | 6 | -5 |
| 18 Jan | vs PAR | L 57-87 | 3 | 0 | 1 | 0 | 0 | 1 | -2 |
| 12 Jan | @ IGO | L 82-91 | 11 | 3 | 0 | 1 | 0 | 4 | -10 |
| 30 Dec | @ MEG | L 91-95 | 14 | 9 | 1 | 0 | 0 | 10 | +7 |
| 20 Dec | vs KRK | W 84-81 | 12 | 0 | 4 | 0 | 0 | 4 | -5 |
| 14 Dec | vs BUD | W 89-79 | 12 | 4 | 0 | 0 | 0 | 4 | +4 |
| 8 Dec | @ CZV | L 89-95 | 18 | 12 | 5 | 1 | 1 | 18 | +6 |
| 29 Nov | vs ZAD | W 94-67 | 12 | 9 | 4 | 0 | 0 | 13 | +17 |
| 23 Nov | @ PRI | L 81-86 | 12 | 3 | 5 | 0 | 0 | 8 | -3 |
| 16 Nov | @ COL | L 89-93 | 15 | 9 | 2 | 0 | 0 | 11 | +4 |
| 8 Nov | vs MON | W 92-83 | 19 | 10 | 3 | 0 | 0 | 13 | +8 |
| 2 Nov | @ PAR | L 85-90 | 15 | 9 | 5 | 0 | 0 | 14 | -8 |
| 28 Oct | vs IGO | W 78-73 | 6 | 4 | 0 | 0 | 0 | 4 | -1 |
| 18 Oct | @ CIB | W 81-63 | 7 | 0 | 0 | 0 | 0 | 0 | -11 |
Splits — 2019-20
| Split | GP | MIN | PTS | REB | AST |
|---|---|---|---|---|---|
| Home venue | 9 | 10.3 | 4.0 | 1.4 | 0.1 |
| Away venue | 8 | 13.2 | 7.0 | 2.3 | 0.3 |
| 4+ days rest | 16 | 11.5 | 5.1 | 1.9 | 0.2 |
| Season opener rest | 1 | 15.0 | 11.0 | 0.0 | 0.0 |
Hit rates by line — Points, 2019-20
PointsReboundsAssistsThreesPts+Reb+Ast
| Points line | Last 5 | Last 10 | Season |
|---|---|---|---|
| Over 0.5 – 2.5 | 3/560% | 7/1070% | 13/1776% |
| Over 3.5 | 2/540% | 5/1050% | 11/1765% |
| Over 4.5 | 2/540% | 4/1040% | 8/1747% |
| Over 5.5 – 8.5 | 1/520% | 3/1030% | 7/1741% |
| Over 9.5 | 0/50% | 1/1010% | 3/1718% |
How often Marko Tejic finished above each line. These are our own thresholds, not a sportsbook's — no odds are involved.